HBOT Conversations:
Elena Schertz & Tom Fox (Part 3) – Heart Disease

Elena Schertz, NP and Tom Fox of Extivita-RTP in Raleigh, NC join us in a 5-part series to discuss the extraordinary healing they’ve witnessed through the God-given natural therapy of HBOT. This is Part 2, with a focus on how Hyperbaric Oxygen Therapy is helping people of all ages heal from concussions.

Elena Schetz, NP is the nurse practitioner, and Tom Fox is the Safety Director at Extivita-RTP. Extivita-RTP offers a positive environment for healing, and they encourage anyone seeking a better quality of life to come visit them and experience for themselves the wonder of Hyperbaric Oxygen Therapy.

Subscribe. Join the discussion. Share the hope.

Watch the Podcast

In a Special 5-part series with Extivita’s Nurse Practitioner, Elena Schertz, and Safety Director, Tom Fox, we dive into the extraordinary powers of HBOT, and the healing they have witnessed for a variety of conditions. The following segments preluding are as follows:

Part 1 – HBOT for PTSD (veteran focus)
Part 2 – Concussions & HBOT

In Part 3 of 5, we discuss heart disease and how HBOT can help. Tom explains that one of the first cardiac patients he treated with HBOT was a necrosing cardiac surgical patient who had a necrosing sternum.  The patient’s sternum was black before treatment, and after it was a fuchsia from the returned blood flow!  The cardiac surgeon’s face was priceless as he witness this patient have such an incredible response to HBOT.

Tom states, “I think a lot of the physicians that are out there today, their reason why they haven’t considered hyperbarics is because they haven’t been exposed to it. If they were exposed and they could see what it was capable of doing, it would make the difference.”

Elena informs our host that she hasn’t had anyone come to Extivita to receive HBOT specifically for heart disease, but she has witnessed patients who were getting treated for other conditions benefit from HBOT for heart health.  This is known through ejection fraction measurement, as Elena describes…

“I could say from about three people who have have reported improved ejection fraction from doing hyperbarics alone.”

di Girolamo reflects on a story where he heard from two HBOT patients in their late 60s, who had less than 50% heart function.  They started to use hyperbarics for other reasons, and discovered that after 28 HBOT treatments they now had 70% heart function.  When the Cardiologist asked with amazement, “What did you do?!”, they said we didn’t do anything — just HBOT diving.

The topic of myocarditis arises, and how HBOT can help.  Myocarditis is inflammation around the heart, and in this case, hyperbaric oxygen therapy could have an intimate role in bringing about improvement to the condition. Tom continues to explain how people want to see studies, but most of the studies out there on HBOT are simply not good.

There’s never been a lot of studies about hyperbarics, and the structure of the studies comes into question. Because when we look at the hyperbaric studies that are out there, you look and see that they’re always comparing hyperbarics to slightly pressurized room air. You’ll see that traditionally how they write it up and it could be cerebral palsy, it could be post-traumatic stress disorder, the same write up, just replace the words. Both groups improved from baseline. However, there was no differentiation between the groups.

Tom goes into a discussion about a PhD student at the University of Wisconsin who went the extra mile and looked at the therapeutic effects of hyperbaric air – hyperbaric air at 1.3, slightly pressurized room air. And what he was able to do is document mobilization of stem cells. By doing so, that encouraged the medical community to rethink hyperbaric studies using hyperbaric air as the “control”.

Tom continues to dive into HBOT and heart health in general….

“Just by basis of how hyperbarics works, you can see why that did work, how that was very helpful for these folks who had myocardial infarctions. So with with the re-oxygenation of the heart, with the stem cell mobilization, with growth of new blood vessels, you could see how the heart does start to basically regenerate and get better and heal.”

When your heart is damaged from a heart attack,  it’s like a wound in one of your organs or muscle.  Hyperbarics is known to be incredibly beneficial for wound care, 1500 hospitals across our nation have HBOT chambers that are used often simply for wound care. So, if hypoxia and the inflammation resulting from a cardiac event is causing damage to the heart, hyperbaric oxygen therapy will work to naturally resolve and remove those two things. di Girolamo stresses that you don’t have to be an expert in HBOT to understand this, and if he had a bad heart he’d most certainly be getting hyperbaric treatments, and encourages you to do the same. 

They mention that if you were to have a heart attack, inside a hyperbaric chamber is exactly where you’d want to be so you’re supersaturated with oxygen.  This leads into the reasons why it’s important to pre-condition your body with oxygen prior to heart surgery, or really even any surgery.  Tom references a study, “Research report: the effects of hyperbaric oxygen preconditioning on myocardial biomarkers of cardioprotection in patients having coronary artery bypass graft surgery” and explains that prepping your body for surgery can be critical in achieving a better outcome.

Tom explains, “The number one complication out of cardiac bypass surgery is post-cardiac surgical stroke. If you can actually precondition, you can avoid this.”

Cost savings and money for health and wellness remains a hot topic. Tom educates us that one of the chief things that has always been identified with how health care is practiced in the United States and Canada is it’s a for-profit industry.  But, if we looked at reinstituting a payment process that actually rewarded people for being healthy, managing patients, and avoiding conditions, then we could transition the current medical industrial to be incentivized to make people healthier.  If there was a way to ever do that, using hyperbaric oxygen therapy as one of the key treatments would surely be a huge leap in the right direction.

 

Guests

Elena Schertz, NP

Elena Schertz, NP - Clinic Manager at Extivita RTP

Elena attained her Bachelors of Science in Nursing from Michigan State University and received her Masters of Science in Nursing from Simmons University in Boston, MA. She has been practicing integrative medicine since 2010 and is currently working on her certification in functional medicine from the Institute of Functional Medicine.

Elena worked as a nurse in the pediatric oncology, cardiac, and surgical units at UNC hospitals for 15 years before deciding to work in integrative medicine. After years of working as a nurse, she decided to pursue her graduate degree, completing her masters with honors. She is board certified as a Family Nurse Practitioner (FNP) through the American Nurses Credentialing Center.

Elena’s passion for integrative medicine comes from her knowledge that the mind, body and psych/social/spiritual systems are not separate. The focus of Elena’s practice is to approach each of her patient’s healing process from the perspective of the whole, supported and grounded in safety and evidence-based medicine. She also maintains close consultative relationships with experts in the field to promote and enhance wellness for her patients. Elena joined the wonderful Extivita team in March 2019 and is thrilled to be a part of advancing health and wellness through hyperbaric medicine.

 

Elena Schertz, NP

Thomas M. Fox, MAS,MS, CHT - Safety Director at Extivita RTP

Tom is the Research Physiologist for the Hyperbaric Institute for Research and Training, a division of Island Hyperbaric Centre in Pincourt QC. He has worked in the field of Clinical Hyperbaric Oxygen for the last 30 years. During this time, he has been intimately involved with the implementation and the development of the US Army’s Clinical Hyperbaric Service at Dwight David Eisenhower Army Medical Center. He has provided contract hyperbaric services since 1997. Prior to accepting his current position in Quebec, Canada, Mr. Fox served as the Chief of the Atmospherics Branch of the U.S. Army School of Aviation Medicine, Fort Rucker Alabama. In this capacity, he was responsible for hyperbaric/ hypobaric operations and training of US and NATO aviators, flight surgeons and flight medics. Mr. Fox is a senior army aviator and flew twelve years as a Medical Evacuation Pilot for the US Army.

Tom joined the Extivita team in 2022 as the Safety Director, helping Extivita to maintain a healthy and safe environment for exceptional patient care.

 

Extivita-RTP – Hyperbaric Oxygen Therapy Clinic

2012-D TW Alexander Drive
Durham, NC 27709
919-354-3775
919-354-3776
contact@extivita.org
https://www.extivita.org/

Subscribe Now, It’s Free!

[contact-form-7 id="65934" title="Subscribe"]

Recent HBOT News

Combining infliximab, anti-MAP and hyperbaric oxygen therapy for resistant fistulizing Crohn’s disease.

Fistulizing Crohn’s disease (CD) presents a therapeutic challenge as fistulae are notoriously difficult to heal. Mycobacterium avium ss paratuberculosis (MAP) treatment in CD is gaining attention. We evaluated healing of CD fistula(e) using a novel combination therapy. Nine consecutive patients who failed to heal fistulae on conventional treatment including anti-TNF, were treated with at least three doses of infliximab, 18-30 courses of hyperbaric oxygen therapy and anti-MAP antibiotics comprising rifabutin, clarithromycin and clofazimine. All patients achieved complete healing of fistulae by 6-28 weeks and follow-up for mean 18 months.

Clinical Trial – Dexmedetomidine Versus Magnesium Sulphate for Caesarean Delivery

Regional anesthesia has become more popular in cesarean deliveries because most of the
parturients prefer being awake during the birth process. In addition, regional anesthesia may
be a safer method than general. In spinal anesthesia local anesthetics alone may not be
enough for an effective postoperative analgesia and hemodynamic stability of the patient wich
is crucial during cesarean section. So far many adjuvants have been used to augment the
analgesia produced by intrathecal local anesthetics and to reduce their adverse effects .

Various intrathecal adjuvants to local anaesthetics have found to improve the quality and
extend duration of spinal block. Prolongation of duration of spinal block is desirable both
for long procedures and for postoperative pain relief. Efficacy and safty of intrathecal
magnesium as analgesic adjuvant has been tested by several clinical trails in recent
years.Antinociceptive effect of magnesium appears to be relevant for the management of
chronic and post operative pain. These effects are primarily based on regulation of calcium
influx in to the cell. Magnesium blocks calcium influx and non competitively antagonizes NMDA
channels. NMDA receptor signelling plays an impartent in determining the duration of acute
pain3).) addition of magnesium to spinal anaesthesia improved postoperative analgesia in
orthopedic setting. addition of intrathecal magnesium sulfate to 10 mg bupivacaine plus 25µg
fentanyl prolonged spinal anaesthesia in patients undergoing lower extremity surgery.

Dexmedetomidine is a highly selective 2-adrenergic agonist which has been used as
pre-medication and as an adjuvant to general anesthesia.Dexmedetomidine have several
beneficial actions during perioperative period. They decrease sympathetic tone with
attenuation of the neuroendocrine and haemodynamic response to anaesthesia and surgery,
reduce anaesthetic and opiod requirement, cause sedation and analgesia. Dexmedetomidine was
first introduced into clinical practice as a short term intravenous sedative in intensive
care. Like any other adjuvant dexmedetomidine is not free from adverse effects. Use of
dexmedetomidine is often associated with a decrease in heart rate and blood
pressure.Dexmedetomidine was used to enhance the analgesic property of local anaesthetics
like lidocaine bupivacaine and ropivacaine. In vivo and in vitro studies indicated that these
local anaesthetics had significant neurotoxicity. Dexmedetomidine showed protective or growth
promoting properties in tissues, including nerve cells from cortex. Intrathecal
dexmedetomidine has a neuroprotective effect similar to methylprednisolone.

The mechanism by which intrathecal alpha 2-adrenergic agonists prolong the motor and sensory
block of local anesthetics is not clear. It may be an additive or synergistic effect
secondary to the different mechanisms of action of local anesthetic and alpha 2 adrenergic
agonist. The local anesthetics act by blocking sodium channels, whereas the alpha 2
adrenergic agonist acts by binding to pre synapyic C fibre and post synaptic dorsal horn
neurons. Intrathecal alpha 2 adrenergic agonist produce analgesia by depressing the realease
of C fibre transmission by hyperpolarization of post synaptic dorsal horn neurons. Li et al
observed that Glutamate is involved in excitatory neurotransmission nociception and plays an
essential role in relaying noxious stimuli in the spinal cord. Intrathecal injection of alpha
2 adrenergic agonists produces potent antinociceptive effects by altering spinal
neurotransmitter release and effectively treats acute pain.